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ABSTRACT 
The risk assessment of antimicrobial resistance is very important to determine the risk of decreasing antimicrobial 
efficacy can be used as a basis for policymakers in allowing or prohibiting the use of an antimicrobial. This study aims to 
assess the risk of using colistin against E. coli resistance in the broiler flock. Risk assessment is carried out qualitatively 
using primary data, interviews, and secondary data. To obtain primary data various studies were carried out including 
monitoring the prevalence of colistin-resistant E. coli and mcr-1 also mcr-2 genes in broiler flocks, mcr-1 gene transfer 
from E. coli to Salmonella Enteritidis, mcr-1 gene sequencing, mutant selection windows of colistin against E. coli, and 
also multiresistant of E. coli colistin-resistant. Assessment of the risk of E. coli colistin-resistant in the broiler flocks 
through direct contact with live broiler flock environment with the resulting assessment is a medium risk with low 
uncertainty. Since colistin sulfate is very critically important for humans, the reduced use of colistin sulfate in animal 
production is necessary to reduce the risk of resistance. Reducing the use of colistin sulfate requires the collaboration 
of various sectors such as the government, veterinary drugs industries, farmers, and consumers. 
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ABSTRAK 
Penilaian risiko resistansi antimikrob sangat penting untuk menentukan risiko yang disebabkan penurunan daya 
efikasi antimikrob dan dapat digunakan sebagai dasar ilmiah bagi pemerintah untuk melarang atau mengijinkan 
penggunaan suatu antimikrob. Tujuan dari penelitian ini adalah untuk menilai risiko penggunaan kolistin terhadap 
resistansi kolistin pada E. coli di flok broiler. Penilaian risiko dilakukan secara kualitatif dengan menggunakan data 
primer, wawancara, dan data sekunder. Untuk mendapatkan data primer dilakukan berbagai penelitian, antara lain 
monitoring prevalensi E. coli resistan kolistin, gen mcr-1, serta mcr-2 di kandang broiler, transfer gen mcr-1 dari E. coli ke 
Salmonella Enteritidis, sekuensing gen mcr-1, mutant selection windows kolistin terhadap E. coli, dan multi resistansi E. 
coli resistan kolistin. Hasil penilaian risiko E. coli resistan kolistin pada flok broiler melalui kontak langsung dengan 
broiler hidup dan lingkungan kandang adalah medium dengan ketidakpastian rendah. Kolistin sulfat sangat penting bagi 
manusia oleh sebab itu penurunan penggunaan kolistin sulfat di hewan produksi harus dikurangi untuk menurunkan 
risiko akibat resistansi. Penurunan penggunaan kolistin memerlukan kerjasama berbagai sektor seperti pemerintah, 
industri obat hewan, peternak, dan konsumen.  
Kata kunci: kolistin sulfat, mcr-1, penilaian risiko, resistansi, broiler 
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INTRODUCTION 
The use of colistin sulfate in food production, 
which is the last drug choice for human as treat-
ment of multiresistant gram-negative bacterial in-
fections, raise a high interest in the world. Especially 
since the discovery of the mobilized colistin re-
sistant-1 (mcr-1) gene that can be transferred via 
plasmids in 2015 by Liu et al. (2015). This gene is 
transmissible to other bacteria and causes many 
countries to begin to reduce the use of colistin sul-
fate in animal production. Nevertheless, the prohibi-
tion on the use of an antimicrobial must go through 
scientific studies to produce valid results, such as by 
risk assessment. 
 Risk assessment is part of a risk analysis that is 
very helpful for the government in making policies 
that are useful for assessing and managing risks to 
human and animal health regarding the increased 
antimicrobial resistance used in animals (OIE 2016). 
Antimicrobial risk assessment based on CODEX 
(2011) consists of hazard identification, hazard ex-
posure, hazard characterization, and risk characteri-
zation. Until the time this research began, studies 
on the assessment of the risk of bacterial resistance 
due to the use of antimicrobials in production ani-
mals qualitatively and quantitatively have never 
been done in Indonesia. 
We consider, along the supply chain of broiler 
meat, there are four main pathways of resistant-
colistin E. coli exposes to humans. The first pathway 
is in broiler flocks, the second pathway is at a small 
slaughterhouse, the third pathway is in traditional 
markets through broiler fresh meat, and the last 
pathway is through broiler cooked meat products. 
In this paper, we only present an assessment of the 
risk of exposure to colistin-resistant E. coli in broiler 
flocks. The purpose of this study was to conduct a 
qualitative risk assessment of colistin sulfate on the 
emergence of colistin resistance in E. coli in broilers 
regarding the risk of human exposure to colistin-
resistant E. coli in broiler flocks. It is hoped, this risk 
assessment can be used as consideration for deter-
mining the continued use of colistin sulfate in food 
animals, especially broilers in Indonesia. 
 
 
MATERIAL AND METHODS 
The study was conducted from November 2016 
until January 2019 and principally generate primary 
and secondary data. Primary data collection was 
carried out by in vivo and in vitro effect of colistin 
sulfate exposure on E. coli resistance, conducting 
broiler supply chain modeling experiments in the 
laboratory 
laboratory, sampling in 47 flocks that use colistin 
sulfate (cloacal swabs, drinking water, and litters) to 
obtain the prevalence of colistin-resistant E. coli as 
well as mcr-1 and mcr-2 genes in 5 districts in Bogor-
Indonesia, serotyping of E. coli O157:H7, question-
naires, expert opinions, gene transfer mcr-1 to S. 
Enteritidis, sequencing of the mcr-1 gene, multi-
resistance of E. coli resistance colistin isolates, and 
mutant prevention concentration (MPC) research. 
The collection of secondary data was conducted 
thorough studies of scientific publications, un-
published data, and expert opinions. The risk as-
sessment was made by using the data above to 
generate a qualitative risk assessment that devel-
oped from CODEX (2011) dan EMA (2018). Some 
parts of those researches have been published sep-
arately (Palupi et al. 2018a; Palupi et al. 2018b, and 
Palupi et al. 2019). 
 
Hazard Identification, Exposure Assessment, and 
Hazard Characterization 
To conduct hazard identification, various 
information about colistin sulfate and E. coli are 
needed, such as the prevalence of colistin-resistant 
E. coli, determination of resistance, the occurrence 
of cross-resistance or co-resistance, and minimum 
inhibitory concentration (MIC) data of colistin 
sulfate against E. coli. The information needed in the 
exposure assessment of colistin-resistant E. coli 
includes the description of colistin veterinary drug 
products circulating in Indonesia, the use of colistin 
in broilers, suppression of colistin resistance 
selection, the occurrence and rate of transfer of 
resistance, colistin concentration in the intestine 
lumen, selective windows of colistin sulfate, the 
prevalence of colistin-resistant E. coli from living and 
environmental broilers, and personnel 
characterization that can be directly exposed to 
colistin-resistant E. coli (Codex 2011, EMA 2018) 
The information needed in assessing the hazard 
characterization of colistin-resistant E. coli from 
broilers to humans is the use of colistin sulfate for 
humans and the consequences if humans are 
exposed to colistin-resistant E. coli. The required 
details include the presence of colistin sulfate and 
its alternatives, the prevalence of colistin-resistant 
bacterial infection in humans, and the horizontal 
spread of resistance. 
 
The Likelihood Categorization of Exposure As-
sessment and Risk Characterization 
Qualitative risk assessment was analyzed according 
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to the stages in the CODEX CAC / GL 77-2011 docu-
ment: Guidelines for Analysis of Foodborne Antimi-
crobial Resistance. Explanation or interpretation of 
hazard assessment is presented in Table 1. 
The results of the exposure assessment are 
obtained by making a likelihood assessment of each 
node in the pathway of exposure. The exposure 
assessment of each pathway was carried out using a 
combination of the likelihood combination matrix in 
Table 2 that developed from AFFA (2001). 
If multiple exposures are found in the pathway, 
the overall qualitative risk scoring for the exposure 
assessment is as follows: (1) if one of the partial 
risks is high, then the overall risk is also high; (2) if 
more than one partial risk is medium, overall risk is 
high; (3) if one partial risk is medium and the other 
partial risk (more than one) is low, the overall risk is 
high; (4) if there is one medium partial risk and the 
other partial risk is not medium, then the overall risk 
is medium; (5) if all partial risks are low, overall risk 
is medium; (6) if one or more partial risks is low, 
overall risk is low; and (7) if all partial risks can be 
neglected, the overall risk is negligible. 
After conducting exposure assessment, the next 
step is to conduct a hazard characterization 
assessment. Interpretations of hazard 
characterization assessments are listed in Table 3. In 
a qualitative risk assessment is important to 
understand the level of uncertainty of the 
information used. Categorization of information 
uncertainty using EFSA (2006), which are low, 
medium, and high uncertainty. The final step in 
assessing risk is to assess  risk  characterization. Risk 
characterization assessment is done by combining 
the results of exposure assessment and hazard 
characterization is presented in Table 4 (CODEX 
2011). 
 
 
RESULTS AND DISCUSSION 
Hazard Identification: Colistin sulfate and Colistin-
resistant Escherichia coli 
Colistin sulfate is a polymixin antibiotic used in 
animals and humans. Since 2017, polymyxin is cate-
gorized as the Highest Priority Critically Important 
Antimicrobials for Human Medicine (WHO 2017). 
Colistin sulfate has been used for decades in food 
animals as a therapy, prevention of infection, and as 
growth promotor. Colistin is very difficult to absorb 
by the digestive tract of broiler chickens (Lashev 
and Haritova 2003). Some commercial colistin sul-
fate veterinary drugs contain a single colistin sulfate 
and some are combined with other antimicrobials 
(EMA 2013; DGLAHS 2016). 
Escherichia coli is a commensal bacterium that 
very important in monitoring and surveillance anti-
microbial resistance in food animals and their prod-
ucts. The commensal bacterium is considered as a 
reservoir of antimicrobial resistance genes, which 
can transfer these genes to pathogenic bacteria 
(OIE 2016). Meanwhile, Escherichia coli serotype 
O157: H7 is a pathogenic zoonotic bacterium for 
humans (Riemann and Cliver 2006; Ferens and 
Hovde 2011). Food animals along with their products 
and their  environments also considered a factor in 
the increasing or spreading of resistant bacteria. 
  
 
Table 1 The qualitative interpretation of likelihood human exposure to colistin-resistant Escherichia coli 
Assessment Interpretation 
Negligible The probability of exposure for susceptible people is extremely low so it can be negligible 
Low The probability of exposure for susceptible people is low but possible 
Medium The probability of exposure for susceptible people is likely 
High The probability of exposure for susceptible people is certain or very high 
 
 
Table 2 Likehood matrix combination of exposure assessment of colistin-resistant E. coli 
Likelihood 2 
Likelihood 1 
High Medium Low Negligible 
High High Medium Low Negligible 
Medium Medium Low Low Negligible 
Low Low Low Negligible Negligible 
Negligible Negligible Negligible Negligible Negligible 
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The mechanism of resistance of E. coli to colistin 
is known through (1) mutations in specific regions, 
such as pmrA / B and phoP / Q, (2) mutations in the 
structure of lipopolysaccharide in the cytosol (ParR-
ParS system), and (3) addition of phosphoethano-
lamine to lipid A that mediated by the mobilized col-
istin-resistant (mcr) genes (Fernández et al. 2010; 
Moskowitz et al. 2012; Liu et al. 2015). Co-resistance 
can occur with other polymyxin groups and several 
cationic peptides (Napier et al. 2013; Catry et al. 
2015). 
The spread of the mcr-1 gene can be through 
plasmids or conjugation, transposon composites, 
transformation, and chromosomes (Hadjaj et al. 
2017; Lima Barbieri et al. 2017; Tada et al. 2017a; Sun 
et al. 2018). Our study also succeeded in transferring 
this gene from colistin-resistant E. coli to S. Enter-
itidis ATCC 13076 through conjugation (Palupi et al. 
2018a). Escherichia coli is the most common bacteria 
found to have mcr-1 gene (Poirel et al. 2016).  
Our study showed that the prevalence of colistin-
resistant E. coli along the broiler supply chain in Bo-
gor was 11.76% (95% CI; CL 9.21-14.91%) with mcr-1 
gene prevalence of 10.55% (95% CI; CL 8.13-13.57%) 
(Palupi et al. 2019). Our study also showed a very 
high agreement between colistin-resistant pheno-
type and mcr-1 genes genotype (89.66% conformity 
with a value of ĸ 0.939), we didn’t find mcr-2 gene, 
the MIC value of E. coli susceptible to colistin sulfate 
 
 
was 0.125-2 µg / mL, and the MIC value of colistin-
resistant E. coli was 4 to > 32 µg/ mL. 
 
 Exposure  Assessment  Colistin-resistant Esche-
richia coli to Humans in Broiler Flocks 
Food animals and their environment are consid-
ered as one reservoir of resistant bacteria that can 
transfer directly or indirectly to humans (Marshall 
and Levy 2011; WHO 2016). We consider two major 
exposure branches pathway in the pathway expo-
sure of colistin-resistant E. coli to humans in broiler 
flocks. First branches are through direct contact 
with live broilers and second branches are exposure 
through flock environment that contaminated with 
colistin-resistant E. coli (Figure 1). Assessment of 
exposure through direct contact with live broilers 
involves two likelihood nodes, the first node is col-
istin-resistant E. coli in broilers due to the usage of 
colistin sulfate in the broiler (L1) and the likelihood 
of the process of human get exposed to colistin-
resistant E. coli from live broilers (L3). The exposure 
pathway through the flock environment involved 3 
likelihood nodes which are colistin-resistant E. coli 
derived from broilers (L1), the likelihood of flock 
environment get contaminated with colistin-
resistant E. coli (L2), then the likelihood of colistin-
resistant E. coli exposes humans through contact 
with the flock environment (L3). 
 
 
Table 3 Interpretation of likelihood assessment of hazard characterization colistin-resistant Escherichia coli 
qualitatively 
Categories Interpretation 
Negligible No adverse human health impact or consequences  
Low Symtoms are minimally bothersome and no therapy are needed 
Medium 
 
Symtoms are more pronounced than low categories but not life threatening. If an infection 
occurs, treatment is needed as indicated. 
High or severe 
 
Symtoms are potentially life threatening and requaire systemic treatment or hopitalization. 
Increase severity may occur due foodborne resistant bacteria.  
Very highor fatal Directy or indirectly contributes to the death infected patient, treatment failure is likely 
expected due to foodborne resistant microorganism. No alternative treatment beside using 
colistin sulfate  
 
 
Table 4 Matrix combination of risk characterization assessment colistin-resistant Escherichia coli  
Exposure assessment 
Hazard characterization   
Negligible Low Medium High Very hIgh 
Negligible Negligible Low Low Low Low 
Low Negligible Low Low Medium High 
Medium Low Medium Medium High Very high 
High Low Medium High Very high Very high 
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Likelihood Assessment Broiler with Colistin-
Resistant Escherichia coli Due The Usage of Col-
istin Sulfate (L1) 
Based on observations and questionnaires, per-
sonnel who can contact with chickens and the flocks 
environment are flock workers, health technical 
services (eg veterinarians), one-day-old chicken 
(DOC) senders, broiler collectors, broiler catchers, 
and litter collectors. Direct contact between broilers 
and humans in the flock, intensively occurs when 
the chick in, checking the weight (once a week), and 
the harvest period.  
Commercial E. coli is very rarely found in DOC. In 
our study (Palupi et al. 2018a), only 5.56% DOC was 
found with commensal E. coli and none were re-
sistant to colistin. At the time of harvest, the per-
sonnel most frequently contacted with broilers are 
flock workers, bird collectors, and bird catchers. 
Other visitors who can contact the broiler in the 
flock are technical health service (25.5%) and DOC 
sender (25.5%). 
Broiler farmworkers generally do not wear per-
sonal protective equipment (PPE) when working, 
eg. gloves, boots, wear packs, or masks (Figure 2). 
Visitors are also not provided with personal protec-
tive equipment. After working, 42.6% of workers 
simply cleaned themselves with water, 42.6% 
cleaned themselves with soap, and only 14.8% 
cleaned themselves with soap and with disinfect-
ants, such as 70% alcohol. 
 
The personnel most often in contact with litter 
and drinking water are flock workers. There is a litter 
collector that takes the litter when the broiler har-
vest is finished. When collecting litters, they do not 
use adequate PPE. Information on the use of PPE is 
crucial in taking litter because litter is a good medi-
um for the development of pathogenic microbes. 
Escherichia coli O157: H7 can survive in the litter for 
42-49 days at 37ºC, 46-56 days at 22ºC, and 63-70 
days at 5ºC (Solimanet et al. 2018). 
Based on the assessment of the characteristics of 
E. coli, the prevalence of colistin-resistant E. coli with 
mcr-1 gene, resistance distribution patterns, raising 
management of broiler, and biosecurity practices in 
broiler flocks, colistin-resistant E. coli with mcr-1 
gene may expose humans. Research conducted by 
Trung et al. (2017), showed that farmers who were 
exposed to broiler positive mcr-1 showed a higher 
risk of colonization of bacteria carrying mcr-1 than 
those that were not directly exposed to chickens or 
with farmers whose chickens did not have the mcr-1 
gene. 
Humans who are most likely to be exposed are 
flockworkers, then bird catchers, and litter collec-
tors. Based on the evaluation of the information, 
the L3 exposure assessment is medium with low 
uncertainty. The uncertainty of information in mak-
ing this exposure assessment is low because based 
on references, observations that give the same re-
sults, and interviews with experts also give the 
same opinion. 
 
 
 
 
Figure 1    Exposure pathway resistant-colistin E. coli to human in broiler flock. The first exposure is through 
direct contact with live broiler (L1 x L3) and the second is through the environment at flocks 
(L1 x L2 x L3) 
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Results of Likelihood Exposure Assessment of Col-
istin-resistant Escherichia coli to Humans in Broil-
er Flocks 
Calculation of likelihood for human exposure by 
colistin-resistant E. coli from broilers flocks is ob-
tained using a combination matrix of Table 2. The 
results of the likelihood exposure assessment of 
colistin-resistant E. coli to humans through direct 
contact with broilers (first branch pathway) are low 
with low uncertainty. This low assessment is ob-
tained from the possibility of L1 (medium) x L3 (me-
dium). 
The likelihood of human exposure assessment by 
colistin-resistant E. coli through the flock environ-
ment is low, this likelihood exposure assessment 
involves L1 (medium) x L2 (low) x L3 (medium). The 
uncertainty through this pathway is also low. Low 
uncertainty assessment based on the majority of 
information sources obtained based on primary da-
ta, references that are very supportive and not con-
tradictory, questionnaire results, and expert opin-
ions that do not conflict with each other. The overall 
exposure assessment of colistin-resistant E. coli to 
humans at the broiler flock level uses the principle 
of multiple exposures in that the values are medium 
(low + low) with low uncertainty (Table 5). 
 
Hazard Characterization of Human Exposure by 
Colistin-Resistant Escherichia coli in Broiler Flock 
Information for hazard characterization is ob-
tained through scientific publications and direct 
communication with Dr. Harry Parathon, SpOG (K). 
The use of colistin in Indonesia is very limited because 
it is used as the last drug choice for the treatment of  
pan-resistance.  Colistin  for the  treatment of pan-
resistant cases is difficult to obtain but in some large 
hospitals, it is provided as alternative medicine. 
Based on communication in July 2018, colistin meth-
anosulfonate (injection) has not yet included in the 
health system and is likely to be held in the coming 
year. Based on communication with experts, it was 
mentioned that the prevalence of cases of pan-
resistant human infection in Indonesia is still very 
low. 
The prevalence of colistin-resistant E. coli-
positive mcr-1 gene infections in hospitalized pa-
tients has been studied in several countries and 
ranges from 0% - 1.4% (Kim et al. 2017; Terveer et al. 
2017; Principe et al. 2018). The higher prevalence is 
indicated by Eiamphungporn et al. (2018) in Thai-
land, reaching 27.7%. In the hazard characterization 
assessment of E. coli zoonosis, our study used E. coli 
serotype O157: H7. Colistin-resistant E. coli O157: H7 
isolates with mcr-1 gene were only found in one iso-
late out of a total of 380 E. coli isolates from live 
broiler and flock environment (0.31%) or the preva-
lence was very low. Several studies have shown that 
colistin-resistant E. coli with mcr-1 from food animals 
and pets can move to humans (Olaitan et al. 2015; 
Zhang et al. 2016; Tada et al. 2017b). 
In our study, 95.59% of colistin-resistant E. coli 
isolates were also found to be multiresistant (Palupi 
2019). Colistin-resistant E. coli infections can still be 
treated with other antibiotics as long as the infect-
ing bacteria are not multiresistant to the antimicro-
bial used. Therefore, based on the information ob-
tained, the hazard characterization assessment of 
human exposure by colistin-resistant E. coli in broiler 
flocks is medium with low uncertainty. 
 
 
 
 
Figure 2   Flockworkers do not use proper PPE 
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Risk Characterization of Colistin-Resistant Esche-
richia coli in Broiler Flock to Humans 
The final step in risk assessment is to carry out 
risk characterization based on exposure assessment 
pathway and hazard characterization assessment. 
The risk characterization assessment uses a combi-
nation of exposure assessment and hazard charac-
terization matrix as in Table 4. The results of the risk 
characterization exposure assessment through the 
broiler flock are medium (medium x medium) with 
low uncertainty. The results of the risk characteriza-
tion assessment are in Table 6. 
 
Risk Mitigation of Colistin-Resistant Escherichia 
Coli from Broiler Flocks to Humans Health 
The veterinary medicine industry plays an im-
portant role in the circulation of colistin sulfate. Ful-
fillment of pharmacological data and colistin sulfate 
resistance from animal drugs to be registered must 
be tightened based on scientific data per product. In 
2016 the European Committee for Medicinal Prod-
ucts for Veterinary Use (CVMP) requested that all 
colistin sulfate combinations with other oral antimi-
crobials be withdrawn from the European Union 
(EMA 2016). Approval for the registration of animal 
drug colistin sulfate combined with other antimicro-
bials must go through in-depth scientific evaluation. 
Good farm management will reduce the risk of 
pathogenic  bacterial  infection.  This will  reduce the 
dependence of farmers on antimicrobials to prevent 
infection. The use of proper PPE to reduce the risk 
of direct contact with colistin-resistant E. coli also 
needs to be done when handling chickens, working, 
and taking litter in the farm. The use of PPE will 
greatly help reduce risks, especially for small scale 
broiler farms which are difficult to implement in 
three zones of livestock. 
Education about the position of colistin sulfate to 
farmers or health managers on broiler farms is also 
very important. Farmers and health managers need 
to understand the importance of colistin for human 
health so as not to choose colistin sulfate as the first 
choice in handling cases of gram-negative bacterial 
infections in broilers. 
 
 
CONCLUSION 
Risk assessment of colistin-resistant E. coli risk in 
broiler flock through direct contact with live broilers 
and the enclosure environment to humans is medi-
um with low uncertainty. This is due to the use of 
colistin sulfate which is the highest priority critically 
important antimicrobials for humans in broilers, the 
presence of the mcr-1 gene that is easily transferred 
between bacteria, low biosecurity at the farm, con-
tamination in the farm environment, and low use of 
PPE in the farm. Therefore, reducing the use of col-
istin sulfate in production animals is a necessity that 
cannot be avoided. 
 
 
 
 
 
Table 5 Recapitulation of exposure assessment colistin-resistant Escherichia coli to humans in broiler flock 
 
Pathway description Assessment Uncertainty 
Exposure of colistin-resistant E. coli to humans in broiler flock 
through direct contact with broilers 
Low Low 
Exposure of colistin-resistant E. coli to humans in broiler flock 
through direct contact with the flock environment 
Low Low 
Total exposure assessment (first + second branch pathway) Medium Low 
 
 
Table 6 Assessment of the risk characterization of colistin-resistant in Escherichia coli in the broiler 
flocks to humans 
 
Description exposure pathway 
Likelihood 
Exposure 
(E) 
Hazard characteriza-
tion (H) 
Risk characterization 
(E x H) 
Uncertainty 
Exposure of colistin-resistant 
E. coli to human in broiler flock 
Medium Medium Medium Low 
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